(Q37458859)

20 August 2017

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension (English)

1 reference

20 August 2017

arterial hypertension

0 references

1 reference

Bożena Romanowska-Dixon

5

object named as

Bozena Romanowska-Dixon

1 reference

20 August 2017

6

Roman Gos

1 reference

20 August 2017

Miguel A Teus

1

1 reference

20 August 2017

Stefano Miglior

2

1 reference

20 August 2017

Guna Laganovska

3

1 reference

20 August 2017

Lāsma Volksone

4

1 reference

20 August 2017

Gábor Holló

7

1 reference

20 August 2017

language of work or name

English

0 references

publication date

16 November 2009

1 reference

20 August 2017

Clinical Ophthalmology

1 reference

20 August 2017

3

1 reference

20 August 2017

629-636

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

20 August 2017

start time

1 November 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

Predictors of long-term progression in the early manifest glaucoma trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

Fixed combinations of topical glaucoma medications

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

Impact of intraocular pressure regulation on visual fields in open-angle glaucoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

Duration of IOP reduction with travoprost BAK-free solution

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glauc

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788589

Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension

2 September 2018

1 reference

12 December 2020

Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma

1 reference

12 December 2020

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group

1 reference

12 December 2020

Compliance in patients prescribed eyedrops for glaucoma

1 reference

12 December 2020

Identifiers

DOI

10.2147/OPTH.S8011

1 reference

20 August 2017

1 reference

20 August 2017

1 reference